GlassScriptPhysician profile
Sheri L Shaffer
NPI 1255844809
$5,650.64
in general payments reported to CMS, 2019-2025
50 companies · $826 in 2025
The $826 reported for 2025 was more than what 82% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,183 · 2022: $1,490 · 2023: $1,177 · 2024: $975 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,887 · Education: $90.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,886.88 |
| Education | $90.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,197.67 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.04 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $397.18 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $272.13 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $258.61 | 2021-2025 | Breztri, Fasenra, Airsupra |
| Incyte Corporation | $221.89 | 2021 | |
| Astellas Pharma US INC | $209.38 | 2021-2025 | Veozah |
| Merck Sharp & Dohme LLC | $202.19 | 2022-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $180.67 | 2022-2024 | Xarelto |
| Celgene Corporation | $158.11 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $154.33 | 2022-2023 | Quviviq |
| Amgen INC. | $151.85 | 2021-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $145.00 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Array Biopharma INC | $112.07 | 2021-2024 | Braftovi, Lorbrena, Mektovi |
| Currax Pharmaceuticals LLC | $109.02 | 2022-2025 | Nexletol, Contrave, Nexlizet |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheri Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.